Analyst Ratings for Compass Therapeutics (CMPX)
CMPX Rating Summary
CMPX Price Target Summary
- Highest: $24.00 (H.C. Wainwright)
- Lowest: $6.00 (Stifel)
- Average: $11.78
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.78 (+477.3%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Avg. $ Target:
$11.78 (+477.3%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/28/2026 | Raymond James | Sean McCutcheon | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
1.79 (2.04) |
13.97% | Details |
| 2/13/2026 | Craig-Hallum | N/A | New Coverage | Buy (N/A) |
15.00 (N/A) |
6.34 (2.04) |
-67.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
